Clinical Trials Directory

Trials / Unknown

UnknownNCT05945043

Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion

Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion (COSINE)

Status
Unknown
Phase
Study type
Observational
Enrollment
124 (estimated)
Sponsor
Guy's and St Thomas' NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to better understand the relationship between pleural effusions and breathlessness in patients with unilateral pleural effusions and breathlessness who require pleural fluid removal for its management.

Detailed description

This study will involve 124 adult patients who are breathlessness with pleural effusions. They will be recruited from a single UK centre over an 18-month period. After being informed about the study, all patients giving written informed consent will undergo a baseline assessment when they first come to have their fluid drained. The investigators will record information about them and their disease. The investigators will take measurements of their breathlessness, their breathing muscles, and the electrical activity from the brain to those muscles. These will be taken at the start and end of drainage, as well as 1 day and 7 days after. The investigators will use this information to look for links between the effect of pleural effusions and its removal on the electrical activities of the breathing muscles and patients' breathlessness.

Conditions

Interventions

TypeNameDescription
OTHERSurface parasternal eletromyogramThe surface parasternal EMG of participants will be measured pre, immediately post and at days 1 and 7 following pleural fluid removal
OTHERSurface diaphragm electromyogramThe ipsilateral and contralateral surface diaphragm EMG of participants will be measured pre and immediately post pleural fluid removal
OTHERParasternal muscle ultrasoundThe thickness of the parasternal intercostal muscle of participants will be measured using thoracic ultrasound pre and immediately post pleural fluid removal
OTHERBreathlessness assessmentThe VAS breathlessness score and Dyspnoea-12 questionnaire of participants will be measured pre, immediately post and at days 1 and 7 following pleural fluid removal

Timeline

Start date
2023-11-15
Primary completion
2024-12-01
Completion
2025-01-01
First posted
2023-07-14
Last updated
2024-02-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05945043. Inclusion in this directory is not an endorsement.